| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL(R) | 207 | 34.7% | -1.28 | 85 | 49.1% |
| CA(R) | 157 | 26.3% | -3.49 | 14 | 8.1% |
| CentralBrain-unspecified | 120 | 20.1% | -1.62 | 39 | 22.5% |
| CRE(R) | 78 | 13.1% | -1.64 | 25 | 14.5% |
| PED(R) | 16 | 2.7% | -1.42 | 6 | 3.5% |
| SCL(R) | 18 | 3.0% | -2.58 | 3 | 1.7% |
| aL(R) | 1 | 0.2% | 0.00 | 1 | 0.6% |
| upstream partner | # | NT | conns KCg-s4 | % In | CV |
|---|---|---|---|---|---|
| KCg-m (R) | 111 | DA | 177 | 31.5% | 0.9 |
| KCg-d (R) | 51 | DA | 106 | 18.9% | 0.7 |
| APL (R) | 1 | GABA | 55 | 9.8% | 0.0 |
| DC1_adPN (R) | 1 | ACh | 37 | 6.6% | 0.0 |
| M_adPNm8 (R) | 1 | ACh | 22 | 3.9% | 0.0 |
| DA4m_adPN (R) | 1 | ACh | 20 | 3.6% | 0.0 |
| DP1m_adPN (R) | 1 | ACh | 17 | 3.0% | 0.0 |
| PAM08 (R) | 12 | DA | 16 | 2.8% | 0.5 |
| DA2_lPN (R) | 1 | ACh | 12 | 2.1% | 0.0 |
| VA1d_adPN (R) | 1 | ACh | 12 | 2.1% | 0.0 |
| DPM (R) | 1 | DA | 12 | 2.1% | 0.0 |
| PPL103 (R) | 1 | DA | 11 | 2.0% | 0.0 |
| PAM07 (R) | 5 | DA | 10 | 1.8% | 0.0 |
| PAM01 (R) | 6 | DA | 9 | 1.6% | 0.5 |
| PAM08 (L) | 4 | DA | 8 | 1.4% | 0.5 |
| PAM12 (R) | 3 | DA | 5 | 0.9% | 0.6 |
| PAM01 (L) | 4 | DA | 5 | 0.9% | 0.3 |
| PPL101 (L) | 1 | DA | 4 | 0.7% | 0.0 |
| MB-C1 (R) | 2 | GABA | 4 | 0.7% | 0.0 |
| PPL103 (L) | 1 | DA | 3 | 0.5% | 0.0 |
| DM5_lPN (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| PAM07 (L) | 2 | DA | 2 | 0.4% | 0.0 |
| MBON05 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHCENT4 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| KCa'b'-ap2 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| KCab-s (R) | 1 | DA | 1 | 0.2% | 0.0 |
| KCg-s2 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| KCg-s1 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| PPL102 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.2% | 0.0 |
| PPL101 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| PPL202 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.2% | 0.0 |
| MBON01 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns KCg-s4 | % Out | CV |
|---|---|---|---|---|---|
| KCg-m (R) | 110 | DA | 163 | 30.5% | 0.7 |
| KCg-d (R) | 40 | DA | 81 | 15.1% | 1.0 |
| APL (R) | 1 | GABA | 65 | 12.1% | 0.0 |
| MBON09 (R) | 2 | GABA | 28 | 5.2% | 0.2 |
| MBON05 (L) | 1 | Glu | 21 | 3.9% | 0.0 |
| MBON11 (R) | 1 | GABA | 20 | 3.7% | 0.0 |
| DPM (R) | 1 | DA | 18 | 3.4% | 0.0 |
| PAM08 (R) | 8 | DA | 11 | 2.1% | 0.5 |
| MBON01 (R) | 1 | Glu | 9 | 1.7% | 0.0 |
| MBON12 (R) | 2 | ACh | 9 | 1.7% | 0.1 |
| PAM01 (R) | 7 | DA | 9 | 1.7% | 0.4 |
| PAM08 (L) | 5 | DA | 9 | 1.7% | 0.2 |
| MBON35 (R) | 1 | ACh | 8 | 1.5% | 0.0 |
| PPL103 (R) | 1 | DA | 8 | 1.5% | 0.0 |
| MBON32 (R) | 1 | GABA | 6 | 1.1% | 0.0 |
| PPL101 (R) | 1 | DA | 6 | 1.1% | 0.0 |
| PAM07 (R) | 4 | DA | 6 | 1.1% | 0.6 |
| MBON21 (R) | 1 | ACh | 4 | 0.7% | 0.0 |
| CRE048 (R) | 1 | Glu | 4 | 0.7% | 0.0 |
| LHPV3c1 (R) | 1 | ACh | 4 | 0.7% | 0.0 |
| PPL101 (L) | 1 | DA | 4 | 0.7% | 0.0 |
| MBON27 (R) | 1 | ACh | 3 | 0.6% | 0.0 |
| CRE200m (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| MBON22 (R) | 1 | ACh | 3 | 0.6% | 0.0 |
| LHMB1 (R) | 1 | Glu | 3 | 0.6% | 0.0 |
| PAM12 (R) | 3 | DA | 3 | 0.6% | 0.0 |
| MBON30 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| KCg-s2 (R) | 1 | DA | 2 | 0.4% | 0.0 |
| PPL103 (L) | 1 | DA | 2 | 0.4% | 0.0 |
| MBON20 (R) | 1 | GABA | 2 | 0.4% | 0.0 |
| PAM01 (L) | 2 | DA | 2 | 0.4% | 0.0 |
| MB-C1 (R) | 2 | GABA | 2 | 0.4% | 0.0 |
| MBON29 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MBON33 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| VM6_adPN (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CRE043_d (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| PAM07 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| CRE067 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PAM12 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| KCa'b'-m (R) | 1 | DA | 1 | 0.2% | 0.0 |
| KCab-s (R) | 1 | DA | 1 | 0.2% | 0.0 |
| SMP376 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| DA2_lPN (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL258 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| D_adPN (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL036 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| PPL102 (L) | 1 | DA | 1 | 0.2% | 0.0 |
